Education
About Us
Working with TipRanks
Follow Us
Conmed Corporation (CNMD)
:CNMD
CNMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$55.22 - $81.22
Previous CloseN/A
Volume49.43K
Average Volume (3M)505.10K
Market Cap
$1.88B
Enterprise Value$3.05B
Total Cash (Recent Filing)$24.46M
Total Debt (Recent Filing)$905.78M
Price to Earnings (P/E)14.0
Beta0.61
Next Earnings
Apr 23, 2025EPS Estimate
0.81Last Dividend Ex-Date
Mar 14, 2025Dividend Yield1.34%
Share Statistics
EPS (TTM)4.25
Shares Outstanding30,908,834
10 Day Avg. Volume463,739
30 Day Avg. Volume505,100
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)N/A
Price to Sales (P/S)1.41
Price to Cash Flow (P/CF)10.60
P/FCF Ratio10.00
Enterprise Value/Market Cap1.63
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.17
Enterprise Value/Ebitda11.92
Forecast
1Y Price Target
$77.17Price Target Upside29.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
---
Conmed News
PremiumCompany Announcements
Conmed Expands Board with New Director Appointment
PremiumCompany Announcements
Conmed Corporation Reports Resilient Earnings Growth
PremiumCompany Announcements
CONMED Corporation Reports Strong 2024 Financial Growth
---
Bulls Say, Bears Say
Bulls Say
EarningsCNMD's 4Q24 revenue and EPS beat consensus.
Operational StrategyEfforts to reduce the CNMD leverage profile with a target of ~3x or lower offer the potential for improved performance.
Product DevelopmentThe addition of BioBrace to RCR in high-risk patients resulted in favorable outcomes, including low clinical failure rate at one-year follow-up as well as significant improvements in pain, function, and range of motion.
Bears Say
CompetitionThe report includes concerns around AirSeal in light of new competition.
Execution ChallengesContinuous execution issues make it difficult to give CONMED the benefit of the doubt ahead of another back-end loaded year.
GuidanceManagement provided 2025 revenue and EPS guidance below consensus due to continued supply chain challenges.
---
Ownership Overview
0.78% Insiders
35.31% Mutual Funds
0.61% Other Institutional Investors
36.17% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CNMD FAQ
What was Conmed Corporation’s price range in the past 12 months?
Conmed Corporation lowest stock price was $55.22 and its highest was $81.22 in the past 12 months.
What is Conmed Corporation’s market cap?
Conmed Corporation’s market cap is $1.88B.
When is Conmed Corporation’s upcoming earnings report date?
Conmed Corporation’s upcoming earnings report date is Apr 23, 2025 which is in 28 days.
How were Conmed Corporation’s earnings last quarter?
Conmed Corporation released its earnings results on Feb 05, 2025. The company reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.203 by $0.137.
Is Conmed Corporation overvalued?
According to Wall Street analysts Conmed Corporation’s price is currently Undervalued.
Does Conmed Corporation pay dividends?
Conmed Corporation pays a Quarterly dividend of $0.8 which represents an annual dividend yield of 1.34%. See more information on Conmed Corporation dividends here
What is Conmed Corporation’s EPS estimate?
Conmed Corporation’s EPS estimate is 0.81.
How many shares outstanding does Conmed Corporation have?
Conmed Corporation has 30,908,834 shares outstanding.
What happened to Conmed Corporation’s price movement after its last earnings report?
Conmed Corporation reported an EPS of $1.34 in its last earnings report, beating expectations of $1.203. Following the earnings report the stock price went down -8.976%.
Which hedge fund is a major shareholder of Conmed Corporation?
Currently, no hedge funds are holding shares in CNMD
---
Conmed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$77.17 (29.31% Upside)
$77.17 (29.31% Upside)
Blogger Sentiment
Bullish
CNMD Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 124.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $16.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 8.7%
Last 30 Days ▼ 8.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.72%
12-Months-Change
Fundamentals
Return on Equity
14.74%
Trailing 12-Months
Asset Growth
0.27%
Trailing 12-Months
Company Description
Conmed Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
---
CNMD Company Deck
---
CNMD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong financial performance in certain segments such as General Surgery and AirSeal, with notable improvements in adjusted net income and operating margins. However, challenges such as ongoing supply chain issues in the Orthopedic segment, currency headwinds, and potential tariff impacts were also discussed. The company's focus on resolving these issues and leveraging growth drivers indicates a balanced outlook.Read More>---
CNMD Stock 12 Month Forecast
Average Price Target
$77.17
▲(29.31% Upside)
Technical Analysis
Best Analysts Covering CNMD
1 Year
1 Year Success Rate
9/26 ratings generated profit
1 Year Average Return
+0.55%
reiterated a buy rating 2 months ago
Copying Rick Wise's trades and holding each position for 1 Year would result in 34.62% of your transactions generating a profit, with an average return of +0.55% per trade.
---